Search research articles
Contact Us
Filters
Showing results (111-120 of 126) with videos related to
Page
of 13
Sort By:
Expert Opinion on Biological Therapy
|
June 30, 2021
The impact of anti-TNFα agents on weight-related changes: new insights from a real-world pharmacovigilance study using the FDA adverse event reporting system (FAERS) database
Faizan Mazhar, Vera Battini, Michele Gringeri, et al.
Expert Opinion on Drug Safety
|
August 30, 2014
The importance of monitoring adverse drug reactions in pediatric patients: the results of a national surveillance program in Italy
Carla Carnovale, Tatiana Brusadelli, GianVincenzo Zuccotti, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
July 24, 2014
Impact of therapeutic drug monitoring of antiretroviral drugs in routine clinical management of patients infected with human immunodeficiency virus and related health care costs: a real-life study in a large cohort of patients
Valentina Perrone, Dario Cattaneo, Sonia Radice, et al.
European Journal of Pediatrics
|
October 31, 2018
Central nervous system-active drug abused and overdose in children: a worldwide exploratory study using the WHO pharmacovigilance database
Carla Carnovale, Faizan Mahzar, Sara Scibelli, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 27, 2024
NAT2 Slow Acetylator Phenotype as a Significant Risk Factor for Hepatotoxicity Caused by Antituberculosis Drugs: Results From a Multiethnic Nested Case-Control Study
Stefania Cheli, Alessandro Torre, Marco Schiuma, et al.
Frontiers in Pharmacology
|
June 20, 2022
Antibiotic-Induced Neutropenia in Pediatric Patients: New Insights From Pharmacoepidemiological Analyses and a Systematic Review
Vera Battini, Alessandra Mari, Michele Gringeri, et al.
Psychiatry and Clinical Neurosciences
|
November 27, 2022
Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study
Michele Fusaroli, Valentina Giunchi, Vera Battini, et al.
Journal of Child and Adolescent Psychopharmacology
|
November 20, 2018
Weight-Change Trajectories of Pediatric Outpatients Treated with Risperidone or Aripiprazole in a Naturalistic Setting
Marco Pozzi, Simone Pisano, Giuseppe Marano, et al.
Journal of Clinical Medicine
|
December 9, 2023
Two Years of Active Pharmacovigilance Surveillance and Therapeutic Reconciliation in Frail Populations: The MEAP 3.0 Study
Anna Bombelli, Greta Guarnieri, Niccolò Lombardi, et al.
International Journal of Molecular Sciences
|
May 7, 2025
NAT2 Acetylation Status Predicts Hepatotoxicity During Antituberculosis Therapy: Cumulative Risk Analysis of a Multiethnic Cohort
Marco Schiuma, Sofia Dinegro, Vera Battini, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 126) with videos related to
Sort By:
Page
of 13
Expert Opinion on Biological Therapy
|
June 30, 2021
The impact of anti-TNFα agents on weight-related changes: new insights from a real-world pharmacovigilance study using the FDA adverse event reporting system (FAERS) database
Faizan Mazhar, Vera Battini, Michele Gringeri, et al.
Expert Opinion on Drug Safety
|
August 30, 2014
The importance of monitoring adverse drug reactions in pediatric patients: the results of a national surveillance program in Italy
Carla Carnovale, Tatiana Brusadelli, GianVincenzo Zuccotti, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
July 24, 2014
Impact of therapeutic drug monitoring of antiretroviral drugs in routine clinical management of patients infected with human immunodeficiency virus and related health care costs: a real-life study in a large cohort of patients
Valentina Perrone, Dario Cattaneo, Sonia Radice, et al.
European Journal of Pediatrics
|
October 31, 2018
Central nervous system-active drug abused and overdose in children: a worldwide exploratory study using the WHO pharmacovigilance database
Carla Carnovale, Faizan Mahzar, Sara Scibelli, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 27, 2024
NAT2 Slow Acetylator Phenotype as a Significant Risk Factor for Hepatotoxicity Caused by Antituberculosis Drugs: Results From a Multiethnic Nested Case-Control Study
Stefania Cheli, Alessandro Torre, Marco Schiuma, et al.
Frontiers in Pharmacology
|
June 20, 2022
Antibiotic-Induced Neutropenia in Pediatric Patients: New Insights From Pharmacoepidemiological Analyses and a Systematic Review
Vera Battini, Alessandra Mari, Michele Gringeri, et al.
Psychiatry and Clinical Neurosciences
|
November 27, 2022
Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study
Michele Fusaroli, Valentina Giunchi, Vera Battini, et al.
Journal of Child and Adolescent Psychopharmacology
|
November 20, 2018
Weight-Change Trajectories of Pediatric Outpatients Treated with Risperidone or Aripiprazole in a Naturalistic Setting
Marco Pozzi, Simone Pisano, Giuseppe Marano, et al.
Journal of Clinical Medicine
|
December 9, 2023
Two Years of Active Pharmacovigilance Surveillance and Therapeutic Reconciliation in Frail Populations: The MEAP 3.0 Study
Anna Bombelli, Greta Guarnieri, Niccolò Lombardi, et al.
International Journal of Molecular Sciences
|
May 7, 2025
NAT2 Acetylation Status Predicts Hepatotoxicity During Antituberculosis Therapy: Cumulative Risk Analysis of a Multiethnic Cohort
Marco Schiuma, Sofia Dinegro, Vera Battini, et al.
Page
of 13